World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
78
Citations
22422
World Ranking
1078
National Ranking
35

Christian Steidl publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Christian Steidl sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 419 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Christian Steidl D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Christian Steidl sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 78 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Christian Steidl is affiliated with the University of British Columbia in Canada and has contributed substantially to research in medicine, particularly within the fields of biochemistry, genetics, and molecular biology.

Their work spans several subfields including pathology and forensic medicine, oncology, molecular biology, immunology, and genetics. The primary focus areas in their research involve lymphoma diagnosis and treatment, CAR-T cell therapy research, chronic lymphocytic leukemia research, cancer genomics and diagnostics, immune cell function and interaction, single-cell and spatial transcriptomics, and cancer immunotherapy and biomarkers.

Steidl's recent significant publications include:

  • "Hodgkin lymphoma" (2020), published in Nature Reviews Disease Primers
  • "Genomic profiling for clinical decision making in lymphoid neoplasms" (2022), published in Blood
  • "Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response" (2020), published in Cancer Cell
  • "Toward a New Molecular Taxonomy of Diffuse Large B-cell Lymphoma" (2020), published in Cancer Discovery
  • "TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate" (2020), published in Cell

The scientist frequently publishes in prominent journals, with the largest number of publications appearing in Blood, Hematological Oncology, bioRxiv (Cold Spring Harbor Laboratory), Blood Advances, and Cancer Cell.

Christian Steidl collaborates frequently with several scholars, including:

  • David W. Scott
  • Pedro Farinha
  • Susana Ben-Neriah
  • Ryan D. Morin
  • Kerry J. Savage

Best Publications

  • Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma

    Christian Steidl;Tang Lee;Sohrab P. Shah;Pedro Farinha

  • Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

    Sohrab P. Shah;Ryan D. Morin;Jaswinder Khattra;Leah Prentice

  • Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

    Nathalie A. Johnson;Graham W. Slack;Kerry J. Savage;Joseph M. Connors

  • MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers

    Christian Steidl;Sohrab P. Shah;Bruce W. Woolcock;Lixin Rui

  • New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge

    Julie Schanz;Heinz Tüchler;Francesc Solé;Mar Mallo

  • Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing.

    Ryan D. Morin;Ryan D. Morin;Karen Mungall;Erin Pleasance;Andrew J. Mungall

  • Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies

    David W. Scott;Anja Mottok;Daisuke Ennishi;George W. Wright

  • Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma

    Robert Kridel;Robert Kridel;Barbara Meissner;Sanja Rogic;Merrill Boyle

  • Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma

    Rami Rahal;Mareike Frick;Rodrigo Romero;Joshua M Korn

  • Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.

    Daisuke Ennishi;Aixiang Jiang;Merrill Boyle;Brett Collinge

  • Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma

    David D.W. Twa;Fong Chun Chan;Fong Chun Chan;Susana Ben-Neriah;Bruce W. Woolcock

  • Cooperative Epigenetic Modulation by Cancer Amplicon Genes

    Lixin Rui;N. C.Tolga Emre;Michael J. Kruhlak;Hye Jung Chung

  • Probabilistic cell-type assignment of single-cell RNA-seq for tumor microenvironment profiling.

    Allen W Zhang;Allen W Zhang;Allen W Zhang;Ciara O'Flanagan;Elizabeth A Chavez;Jamie L P Lim;Jamie L P Lim

  • Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition.

    Daisuke Ennishi;Katsuyoshi Takata;Wendy Béguelin;Gerben Duns

  • Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations.

    Britta Will;Li Zhou;Thomas O. Vogler;Susanna Ben-Neriah

  • The molecular pathogenesis of primary mediastinal large B-cell lymphoma

    Unknown

  • IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma

    Chao Wang;Chao Wang;Chao Wang;Timothy W. McKeithan;Qiang Gong;Weiwei Zhang

  • Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS.

    Laura Barreyro;Britta Will;Boris Bartholdy;Li Zhou

  • Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma.

    Jay Gunawardana;Fong Chun Chan;Adèle Telenius;Bruce Woolcock

  • Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study.

    Robert Kridel;Fong Chun Chan;Fong Chun Chan;Anja Mottok;Anja Mottok;Merrill Boyle

Frequent Co-Authors

Randy D. Gascoyne
Randy D. Gascoyne BC Cancer Agency
Joseph M. Connors
Joseph M. Connors University of British Columbia
Ryan D. Morin
Ryan D. Morin Simon Fraser University
Marco A. Marra
Marco A. Marra University of British Columbia
Kerry J. Savage
Kerry J. Savage University of British Columbia
Sohrab P. Shah
Sohrab P. Shah Memorial Sloan Kettering Cancer Center
David Scott
David Scott Ascension Health
Andrew J. Mungall
Andrew J. Mungall BC Cancer Agency
Lisa M. Rimsza
Lisa M. Rimsza Mayo Clinic
Ulrich Germing
Ulrich Germing Heinrich Heine University Düsseldorf

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring molecular biology in the USA opens doors to a wide range of online degrees and flexible career pathways. For students considering a transition into healthcare, online direct entry msn programs for non-nurses provide a fast-track to advanced nursing roles, even for those without a nursing background.

Professionals seeking value in their nursing education may compare programs such as best value nursing education online wgu to identify reputable, cost-effective options. Similarly, those who already have a BSN degree can pursue career growth through online bsn to msn programs, allowing flexible advancement without interrupting employment.

It’s important to select programs from reputable institutions. Choosing non profit online colleges ensures a quality education while often providing better student support and lower tuition compared to for-profit schools.

Whether you’re aiming for a career in research, healthcare, or clinical practice, these online pathways support diverse ambitions within and beyond molecular biology.

Best Scientists Citing Christian Steidl

Trending Scientists